Checkpoint inhibitors: Better outcomes among advanced cutaneous head and neck melanoma patients.
OBJECTIVE:The aim of this study was to investigate if the treatment outcomes of checkpoint inhibitors (CPI) in patients with advanced-stage skin head and neck melanoma (HNM) differs from outcomes in patients with non-HNM. DESIGN:A retrospective cohort study of patients with unresectable AJCC stage I...
Main Authors: | Nir Hirshoren, Roni Yoeli, Jonathan E Cohen, Jeffrey M Weinberger, Nadia Kaplan, Sharon Merims, Tamar Peretz, Michal Lotem |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2020-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0231038 |
Similar Items
-
Immunotherapy Potentiates the Effect of Chemotherapy in Metastatic Melanoma—A Retrospective Study
by: Reut Hadash-Bengad, et al.
Published: (2020-02-01) -
Training and competence perception differences in otolaryngology and head and neck surgery training program – an anonymous electronic national survey
by: Nir Hirshoren, et al.
Published: (2023-11-01) -
Current Treatment Strategies in Cutaneous Malignant Melanoma of the Head and Neck
by: Erdoğan ÖZGÜR, et al.
Published: (2019-04-01) -
Human T cell crosstalk is induced by tumor membrane transfer.
by: Ronny Uzana, et al.
Published: (2015-01-01) -
SLAMF6 deficiency augments tumor killing and skews toward an effector phenotype revealing it as a novel T cell checkpoint
by: Emma Hajaj, et al.
Published: (2020-03-01)